N. Stephen Ober

Dr. Ober is OTD’s Director of Innovation and Entrepreneurship and currently serves as Associate Director of the Health Care Entrepreneurship Program (HCEP) at BU, an academic program designed to train physicians, medical students, and dental students in business and venture creation.
Prior to joining BU in 2004, Dr. Ober was co-founder and president of Beyond Genomics, Inc., a biotechnology company that developed and applied a unique “systems biology” approach to drug discovery and development.
Prior to Beyond Genomics, Dr. Ober was president and chief executive officer of Synergy, a successful health information and data management company.
Synergy was founded by Dr. Ober in 1995 and was acquired by ENVOY Corp.
in 1998.
As part of ENVOY, Synergy developed leading-edge technologies and analytic methods to develop one of the industry’s largest and unique health care data warehouses based on real-time, patient-level electronic claims data.
In March 1999, ENVOY was acquired by Quintiles Transnational, the world’s largest Clinical Research Organization (CRO).
At Quintiles, Dr. Ober successfully integrated Synergy’s data and technology into Quintiles’ drug development processes to improve the efficiency of drug clinical trials.
Prior to Synergy, Dr. Ober spent five years as executive vice president and corporate medical director of Private Health Care Systems (PHCS), one of the largest national managed care companies in the country.
Dr. Ober received his BA and MD degrees from Boston University, his clinical training in surgery and orthopedic surgery from University of California San Diego, and his MBA from the Harvard Graduate School of Business.